The new guidelines, published in European Heart Journal and presented at ESC Congress 2026, show just how much heart failure care has evolved in recent years.

Using NT-proBNP testing kits on high-risk patients with diabetes could help get many more patients the care they need, according to new data published in JACC.

The ACCESS model is designed help more patients get treated and managed with advanced technologies. In addition to heart failure, improved coverage has been announced for Medicare beneficiaries battling COPD, substance use disorders and nicotine dependence.

A majority of TAVR patients also present with a history of heart failure. New research suggests many of them are not being prescribed the medications they need.

There is no question metformin is an effective medication for patients with type 2 diabetes. When it comes to treating heart failure, however, it falls short.

“Our findings do not support routine electrical mapping to target left ventricular lead placement in contemporary CRT practice,” one researcher said. 

A structured, nurse-coordinated, technology-enabled delivery model improved heart failure outcomes in routine care. 

As always, heart team discussions play a vital role when choosing between TAVR and SAVR for patients with large or extra-large aortic annuli.